Work

Corrigendum to “Novel oral nano-hepatic targeted anti-PCSK9 in hypercholesterolemia” [Nanomedicine 40 (2022 Feb); 102480. doi: 10.1016/j.nano.2021.102480]

Year: 2022

Type: erratum

Source: Nanomedicine Nanotechnology Biology and Medicine

DOI: 10.1016/j.nano.2022.102602

Authors: Taher A. Salaheldin, Kavitha Godugu, Dhruba J. Bharali, Kazutoshi Fujioka, Nabil Elshourbagy, Shaker A. Mousa

Institutions: Albany College of Pharmacy and Health Sciences, Shifa Biomedical (United States)

Language: English

Topic: Lipoproteins and Cardiovascular Health

Subfield: Surgery

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4296683294

Cites:

Cited by:

Related to: 10